Anti-CDKN2A/p16INK4a antibody [EPR24167-43] - BSA and Azide free
- BOND RX™ Validated
- KO Validated
- RabMAb
- Recombinant
- What is this?
3
(1 Review)
|
(0 Publication)
Rabbit Recombinant Monoclonal p16INK4A antibody. Carrier free. Suitable for ICC/IF, IP, WB, IHC-P, Flow Cyt (Intra) and reacts with Human, Recombinant full length protein - Human samples.
View Alternative Names
CDKN2, MTS1, CDKN2A, Cyclin-dependent kinase inhibitor 2A, Cyclin-dependent kinase 4 inhibitor A, Multiple tumor suppressor 1, p16-INK4a, CDK4I, MTS-1, p16-INK4, p16INK4A
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] - BSA and Azide free (AB282285)
This data was developed using ab270058, the same antibody clone in a different buffer formulation.
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HeLa cells labelling CDKN2A/p16INK4a with ab270058 at 1/50 (9.36 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 dilution (Green). Confocal image showing nuclear and cytoplasmic staining in HeLa cell line. Negative control : MCF7 (PMID : 10914724) is observed.
ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] - BSA and Azide free (AB282285)
This data was developed using ab270058, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human endometrial cancer tissue labelling CDKN2A/p16INK4a with ab270058 at 1/500 (0.936 ug/ml) dilution followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining in human endometrial cancer. The section was incubated with ab270058 for 30 minutes at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 minutes.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] - BSA and Azide free (AB282285)
This data was developed using ab270058, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized MCF7 ( Human breast adenocarcinoma epithelial cell, Left)/ HeLa (Human cervix adenocarcinoma epithelial cell, Right) cells labelling CDKN2A/p16INK4a with ab270058 at 1/500 dilution (0.1ug) (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody. Negative control : MCF7 (PMID : 10914724).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] - BSA and Azide free (AB282285)
This data was developed using ab270058, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human cervix tissue labelling CDKN2A/p16INK4a with ab270058 at 1/500 (0.936 ug/ml) dilution followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Negative control : No staining in human cervix (PMID : 9736404). The section was incubated with ab270058 for 30 minutes at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 minutes.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] - BSA and Azide free (AB282285)
This data was developed using ab270058, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human cervical cancer tissue labelling CDKN2A/p16INK4a with ab270058 at 1/500 (0.936 ug/ml) dilution followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining in human cervical cancer (PMID : 9736404). The section was incubated with ab270058 for 30 minutes at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 minutes.
- WB
Lab
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] - BSA and Azide free (AB282285)
This data was developed using the same antibody clone in a different buffer formulation (ab270058).
Western blot : Anti-CDKN2A antibody [EPR24167-43] (ab270058) staining at 1/2000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab270058 was shown to bind specifically to CDKN2A. A band was observed at 17 kDa in wild-type HEK-293T cell lysates with no signal observed at this size in CDKN2A knockout cell line. To generate this image, wild-type and CDKN2A knockout HEK-293T cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] (<a href='/en-us/products/primary-antibodies/cdkn2a-p16ink4a-antibody-epr24167-43-ab270058'>ab270058</a>) at 1/2000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
CDKN2A knockout HEK-293T cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
MCF7 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 17 kDa
Observed band size: 17 kDa
false
- WB
Lab
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] - BSA and Azide free (AB282285)
This data was developed using ab270058, the same antibody clone in a different buffer formulation. Western blot : Anti-CDKN2A antibody [EPR24167-43] (ab270058) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab270058 was shown to bind specifically to CDKN2A. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] (<a href='/en-us/products/primary-antibodies/cdkn2a-p16ink4a-antibody-epr24167-43-ab270058'>ab270058</a>) at 1/1000 dilution
Lane 1:
HeLa cell lysate at 20 µg
Lane 2:
HEK-293 cell lysate at 20 µg
Lane 3:
Saos-2 cell lysate at 20 µg
Lane 4:
MCF7 cell lysate at 20 µg
Observed band size: 17 kDa
true
- IP
Supplier Data
Immunoprecipitation - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] - BSA and Azide free (AB282285)
This data was developed using ab270058, the same antibody clone in a different buffer formulation.
CDKN2A/p16INK4a was immunoprecipitated from 0.35 mg HEK-293 (human embryonic kidney epithelial cell), whole cell lysate 10 ug with ab270058 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab270058 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : HEK-293 (human embryonic kidney epithelial cell), whole cell lysate 10 ug
Lane 2 : ab270058 IP in HEK-293 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab270058 in HEK-293 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 32 seconds
All lanes:
Immunoprecipitation - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] (<a href='/en-us/products/primary-antibodies/cdkn2a-p16ink4a-antibody-epr24167-43-ab270058'>ab270058</a>)
Predicted band size: 17 kDa
Observed band size: 16 kDa
false
- IP
Supplier Data
Immunoprecipitation - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] - BSA and Azide free (AB282285)
This data was developed using ab270058, the same antibody clone in a different buffer formulation.
CDKN2A/p16INK4a was immunoprecipitated from 0.35 mg HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate 10 ug with ab270058 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab270058 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate 10 ug
Lane 2 : ab270058 IP in HeLa whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab270058 in HeLa whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 32 seconds
All lanes:
Immunoprecipitation - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] (<a href='/en-us/products/primary-antibodies/cdkn2a-p16ink4a-antibody-epr24167-43-ab270058'>ab270058</a>)
Predicted band size: 17 kDa
Observed band size: 16 kDa
false
- WB
Lab
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] - BSA and Azide free (AB282285)
This data was developed using ab270058, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
This antibody specifically recognizes CDKN2A recombinant protein, but not CDKN2B recombinant protein.
Exposure time : 3.25 seconds
All lanes:
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] (<a href='/en-us/products/primary-antibodies/cdkn2a-p16ink4a-antibody-epr24167-43-ab270058'>ab270058</a>) at 1/1000 dilution
Lane 1:
His-tagged human CDKN2A recombinant protein at 0.01 µg
Lane 2:
GST-tagged human CDKN2B recombinant protein at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 17 kDa
Observed band size: 16 kDa
false
- WB
Lab
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] - BSA and Azide free (AB282285)
This data was developed using ab270058, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Negative control : MCF7, MDA-MB-231 (PMID : 10914724)
The MW observed is consistent with the literature. (PMID : 18053084)
This blot was developed using a higher sensitivity ECL substrate.
Exposure time : 70 seconds
All lanes:
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR24167-43] (<a href='/en-us/products/primary-antibodies/cdkn2a-p16ink4a-antibody-epr24167-43-ab270058'>ab270058</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
HEK-293 (human embryonic kidney epithelial cell), whole cell lysate at 20 µg
Lane 3:
Saos-2 (human osteosarcoma epithelial), whole cell lysate at 20 µg
Lane 4:
MCF7 (human breast adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 5:
MDA-MB-231 (human breast adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 17 kDa
Observed band size: 16 kDa
false
Reactivity data
Product details
ab282285 is the carrier-free version of ab270058.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com